US Stock MarketDetailed Quotes
SGEN Seagen
Watchlist
220.880
+1.900+0.87% Trading 12/11 13:50 ET
221.539High219.000Low1.31MVolume
220.000Open218.980Pre Close289.08MTurnover1.01%Turnover RatioLossP/E (TTM)41.67BMarket Cap221.53952wk HighLossP/E (Static)188.66MShares123.77052wk Low16.34P/B28.68BFloat Cap221.539Historical High--Dividend TTM129.83MShs Float2.150Historical Low--Div YieldTTM1.16%Amplitude220.527Avg Price1Lot Size
About Seagen Company
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.
Company Profile
SymbolSGEN
Company NameSeagen
Listing Date03/07/2001
Issue Price7.00
Founded1997
CEOMr. David R. Epstein
MarketNASDAQ
Employees3256
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address21823 30th Drive South East
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98021
Phone1-425-527-4000
Websitehttp://www.seagen.com
Company Executives
- Name
- Position
- Salary
- David R. Epstein
- Chief Executive Officer and Director
- 57.46M
- Jean I. Liu
- Chief Legal Officer
- 5.95M
- Todd E. Simpson
- Chief Financial Officer and Chief Accounting Officer
- 5.71M
- Dr. Vaughn B. Himes,PhD
- Chief Technical Officer
- 4.54M
- Dr. Roger D. Dansey, M.D.
- President, Research and Development and Chief Medical Officer
- 36.39M
- Charles R. Romp
- Executive Vice President, Commercial U.S.
- 5.03M
- Dr. Felix J. Baker,PhD
- Chairman of the Board
- 528.53K
- David W. Gryska, M.B.A.
- Independent Director
- 483.53K
- Dr. Nancy A. Simonian,M.D.
- Independent Director
- 474.53K
- Dr. Ted W. Love, M.D.
- Independent Director
- 471.03K
- Daniel G. Welch
- Independent Director
- 468.53K
- John A. Orwin
- Independent Director
- 468.53K
- Dr. Alpna Seth, PhD
- Independent Director
- 471.03K
- Sandra M. Swain
- Independent Director
- 214.73K
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--